175 related articles for article (PubMed ID: 25457818)
1. Structural MRI correlates of the MMSE and pentagon copying test in Parkinson's disease.
Garcia-Diaz AI; Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Vendrell P; Bargallo N; Tolosa E; Junque C
Parkinsonism Relat Disord; 2014 Dec; 20(12):1405-10. PubMed ID: 25457818
[TBL] [Abstract][Full Text] [Related]
2. Cortical thinning correlates of changes in visuospatial and visuoperceptual performance in Parkinson's disease: A 4-year follow-up.
Garcia-Diaz AI; Segura B; Baggio HC; Uribe C; Campabadal A; Abos A; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Junque C
Parkinsonism Relat Disord; 2018 Jan; 46():62-68. PubMed ID: 29132765
[TBL] [Abstract][Full Text] [Related]
3. Default mode network connectivity patterns associated with visual processing at different stages of Parkinson's disease.
Rektorova I; Krajcovicova L; Marecek R; Novakova M; Mikl M
J Alzheimers Dis; 2014; 42 Suppl 3():S217-28. PubMed ID: 25114077
[TBL] [Abstract][Full Text] [Related]
4. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
[TBL] [Abstract][Full Text] [Related]
5. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia.
Cormack F; Aarsland D; Ballard C; Tovée MJ
Int J Geriatr Psychiatry; 2004 Apr; 19(4):371-7. PubMed ID: 15065231
[TBL] [Abstract][Full Text] [Related]
6. Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally.
Hanganu A; Bedetti C; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Bruneau MA; Mellah S; Belleville S; Monchi O
Brain; 2014 Apr; 137(Pt 4):1120-9. PubMed ID: 24613932
[TBL] [Abstract][Full Text] [Related]
7. Grey matter atrophy in cognitively impaired Parkinson's disease.
Melzer TR; Watts R; MacAskill MR; Pitcher TL; Livingston L; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):188-94. PubMed ID: 21890574
[TBL] [Abstract][Full Text] [Related]
8. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
[TBL] [Abstract][Full Text] [Related]
9. Cortical thinning associated with mild cognitive impairment in Parkinson's disease.
Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Garcia-Diaz AI; Vendrell P; Bargallo N; Tolosa E; Junque C
Mov Disord; 2014 Oct; 29(12):1495-503. PubMed ID: 25100674
[TBL] [Abstract][Full Text] [Related]
10. Structural Brain Correlations of Visuospatial and Visuoperceptual Tests in Parkinson's Disease.
Garcia-Diaz AI; Segura B; Baggio HC; Marti MJ; Valldeoriola F; Compta Y; Bargallo N; Uribe C; Campabadal A; Abos A; Junque C
J Int Neuropsychol Soc; 2018 Jan; 24(1):33-44. PubMed ID: 28714429
[TBL] [Abstract][Full Text] [Related]
11. Progression of small vessel disease correlates with cortical thinning in Parkinson's disease.
Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Tan L; Kandiah N
Parkinsonism Relat Disord; 2016 Oct; 31():34-40. PubMed ID: 27397577
[TBL] [Abstract][Full Text] [Related]
12. Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia.
Camicioli R; Sabino J; Gee M; Bouchard T; Fisher N; Hanstock C; Emery D; Martin WR
Mov Disord; 2011 Jul; 26(8):1443-50. PubMed ID: 21442661
[TBL] [Abstract][Full Text] [Related]
13. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease.
Pereira JB; Junqué C; Martí MJ; Ramirez-Ruiz B; Bargalló N; Tolosa E
Mov Disord; 2009 Jun; 24(8):1193-9. PubMed ID: 19412935
[TBL] [Abstract][Full Text] [Related]
14. People with Parkinson's disease and normal MMSE score have a broad range of cognitive performance.
Burdick DJ; Cholerton B; Watson GS; Siderowf A; Trojanowski JQ; Weintraub D; Ritz B; Rhodes SL; Rausch R; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Srivatsal S; Edwards KL; Montine TJ; Zabetian CP; Leverenz JB
Mov Disord; 2014 Sep; 29(10):1258-64. PubMed ID: 25073717
[TBL] [Abstract][Full Text] [Related]
15. Progression of cortical thinning in early Parkinson's disease.
Ibarretxe-Bilbao N; Junque C; Segura B; Baggio HC; Marti MJ; Valldeoriola F; Bargallo N; Tolosa E
Mov Disord; 2012 Dec; 27(14):1746-53. PubMed ID: 23124622
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.
Zadikoff C; Fox SH; Tang-Wai DF; Thomsen T; de Bie RM; Wadia P; Miyasaki J; Duff-Canning S; Lang AE; Marras C
Mov Disord; 2008 Jan; 23(2):297-9. PubMed ID: 18044697
[TBL] [Abstract][Full Text] [Related]
17. [Dementia following bipolar disorder].
Lebert F; Lys H; Haëm E; Pasquier F
Encephale; 2008 Dec; 34(6):606-10. PubMed ID: 19081458
[TBL] [Abstract][Full Text] [Related]
18. Cognitive decline correlates with neuropathological stage in Parkinson's disease.
Braak H; Rüb U; Del Tredici K
J Neurol Sci; 2006 Oct; 248(1-2):255-8. PubMed ID: 16814807
[TBL] [Abstract][Full Text] [Related]
19. Shannon entropy: A novel parameter for quantifying pentagon copying performance in non-demented Parkinson's disease patients.
Brabenec L; Klobusiakova P; Mekyska J; Rektorova I
Parkinsonism Relat Disord; 2022 Jan; 94():45-48. PubMed ID: 34883358
[TBL] [Abstract][Full Text] [Related]
20. Fronto-striatal atrophy correlates of inhibitory dysfunction in Parkinson's disease versus behavioural variant frontotemporal dementia.
O'Callaghan C; Naismith SL; Hodges JR; Lewis SJ; Hornberger M
Cortex; 2013; 49(7):1833-43. PubMed ID: 23306064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
